Lv41
625 积分 2021-09-26 加入
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
3小时前
已完结
Discovery of Edecesertib (GS-5718): A Potent, Selective Inhibitor of IRAK4
1个月前
已完结
The regulatory role of NLRX1 in innate immunity and human disease
5个月前
已完结
Pharmacological characterization of AS2690168, a novel small molecule RANKL signal transduction inhibitor
6个月前
已完结
Synthesis and Antiosteoporotic Characterization of Diselenyl Maleimides: Discovery of a Potent Agent for the Treatment of Osteoporosis by Targeting RANKL
6个月前
已完结
Identification of TAK-756, A Potent TAK1 Inhibitor for the Treatment of Osteoarthritis through Intra-Articular Administration
6个月前
已完结
Discovery of the Novel, Orally Active, and Selective LPA1 Receptor Antagonist ACT-1016-0707 as a Preclinical Candidate for the Treatment of Fibrotic Diseases
7个月前
已完结
LPA1 antagonist BMS-986278 for idiopathic pulmonary fibrosis: Preclinical pharmacological in vitro and in vivo evaluation
7个月前
已关闭
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases
7个月前
已完结
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
11个月前
已完结
皖公网安备34019202002308
